This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Parkkali T, Ruutu T, Stenvik M, Kuronen T, Käyhty H, Hovi T et al. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 1996; 104: 383–388.
Ljungman P, de la Camara R, Perez-Bercoff L, Abecasis M, Campuzano JBN, Cannata-Ortiz MJ et al. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica 2011; 96: 1231–1235.
Kumar D, Humar A, Plevneshi A, Siegal D, Franke N, Green K et al. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant 2008; 41: 743–747.
Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, Naparstek E et al. Bacterial pneumonia in recipients of bone marrow transplantation. Transplantation 1995; 60: 672–678.
Kochethu G, Clark FJ, Craddock CF . Pertussis: should we vaccinate post transplant? Bone Marrow Transplant 2006; 37: 793–794.
Machado CM, Goncalves FB, Pannuti CS, Dulley FL, de Souza V . Measles in bone marrow transplant recipients during an outbreak in Sao Paulo, Brazil. Blood 2002; 99: 83–87.
Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarström L, Lönnqvist B, Paulin T et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162: 496–500.
Parkkali T, Stenvik M, Ruutu T, Hovi T, Volin L, Ruutu P . Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 20: 663–668.
Cordonnier C, Ljungman P, Juergens C, Maertens J, Selleslag D, Sundaraiyer V et al. Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged >/= 2 years: an open-label study. Clin Infect Dis 2015; 61: 313–323.
FACT-JACIE. FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing and Administration, 2015. Available at: http://www.jacie.org/standards.
Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143–1238.
Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58: e44–100.
Hilgendorf I, Wolff D, Meisel R . Vaccination of allogeneic haematopoietic stem cell transplant recipients. report from the international consensus conference on clinical practice in chronic GVHD. Vaccine 2011; 29: 2825–2833.
Patel SR, Heath PT, Skinner R Vaccinations for Paediatric Patients Treated with Standard-Dose Chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT) Recipients. Children's Cancer and Leukaemia Group. Leicester, UK, 2014. http://www.cclg.org.uk/write/MediaUploads/Member%20area/Treatment%20guidelines/Vaccinations_for_Children_treated_with_Standard-dose_Chemotherapy_and_HSCT_Recipients-Sept_2014-FINAL_CCLG.pdf.
Meiring J, de Silva TI, Snowden JA . A study of adherence to a vaccination schedule following adult allogeneic haematopoietic stem cell transplants in UK transplant centre. Bone Marrow Transplant 2015; 50(Suppl 1): s203–s204 (abtract P171).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Miller, P., de Silva, T., Skinner, R. et al. Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes. Bone Marrow Transplant 52, 775–777 (2017). https://doi.org/10.1038/bmt.2016.362
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.362